why choose us

First received: February 02, 2023

Clinical Trial: Domvanalimab and Zimberelimab in Advanced Liver Cancers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hepatobiliary Cancer

Study Type: INTERVENTIONAL


Official Title: Phase II Basket Trial of Domvanalimab (AB154) and Zimberelimab (AB122) in Advanced Hepatobiliary Cancers

Brief Summary: The goal of this clinical trial is to learn about advanced liver and bile duct cancers.The main question it aims to answer is:If the combination of Domvanalimab and Zimberelimab are effective in treating advanced hepatobiliary cancers that have failed prior treatment.

Read more